DNA repair pathways and cisplatin resistance: an intimate relationship

CRR Rocha, MM Silva, A Quinet, JB Cabral-Neto… - Clinics, 2018 - SciELO Brasil
The main goal of chemotherapeutic drugs is to induce massive cell death in tumors.
Cisplatin is an antitumor drug widely used to treat several types of cancer. Despite its …

Targeting DNA damage response and repair to enhance therapeutic index in cisplatin-based cancer treatment

RC Kiss, F Xia, S Acklin - International journal of molecular sciences, 2021 - mdpi.com
Platinum-based chemotherapies, such as cisplatin, play a large role in cancer treatment.
The development of resistance and treatment toxicity creates substantial barriers to disease …

Platinum complexes in colorectal cancer and other solid tumors

B Köberle, S Schoch - Cancers, 2021 - mdpi.com
Simple Summary Cisplatin is successfully used for the treatment of various solid cancers.
Unfortunately, it shows no activity in colorectal cancer. The resistance phenotype of …

Molecular mechanisms of cisplatin resistance

L Galluzzi, L Senovilla, I Vitale, J Michels, I Martins… - Oncogene, 2012 - nature.com
Platinum-based drugs, and in particular cis-diamminedichloroplatinum (II)(best known as
cisplatin), are employed for the treatment of a wide array of solid malignancies, including …

New insights into mechanisms of cisplatin resistance: from tumor cell to microenvironment

SH Chen, JY Chang - International journal of molecular sciences, 2019 - mdpi.com
Although cisplatin has been a pivotal chemotherapy drug in treating patients with various
types of cancer for decades, drug resistance has been a major clinical impediment. In …

Cisplatin is a DNA-damaging antitumour compound triggering multifactorial biochemical responses in cancer cells: importance of apoptotic pathways

Y Sedletska, MJ Giraud-Panis… - … Chemistry-Anti-Cancer …, 2005 - ingentaconnect.com
cis-Diamminedichloroplatinum (II)(cisplatin) is among the most active antitumour agent used
in human chemotherapy. The purpose of this review is to give an insight in several …

Cisplatin: mode of cytotoxic action and molecular basis of resistance

ZH Siddik - Oncogene, 2003 - nature.com
Cisplatin is one of the most potent antitumor agents known, displaying clinical activity
against a wide variety of solid tumors. Its cytotoxic mode of action is mediated by its …

Molecular mechanisms involved in cisplatin cytotoxicity

P Jordan, M Carmo-Fonseca* - Cellular and Molecular Life Sciences …, 2000 - Springer
cis-diamminedichloroplatinum (II) or cisplatin is a DNA-damaging agent that is widely used
in cancer chemotherapy. Cisplatin cross-links to DNA, forming intra-and interstrand adducts …

Cellular responses to Cisplatin‐induced DNA damage

A Basu, S Krishnamurthy - Journal of nucleic acids, 2010 - Wiley Online Library
Cisplatin is one of the most effective anticancer agents widely used in the treatment of solid
tumors. It is generally considered as a cytotoxic drug which kills cancer cells by damaging …

Cellular and molecular determinants of cisplatin resistance

RP Perez - European Journal of Cancer, 1998 - Elsevier
Cisplatin and carboplatin are among the most active and widely used cytotoxic anticancer
drugs. However, the acquisition or presence of resistance significantly undermines the …